The Indian markets may see a flat to positive opening
The Indian markets may see a flat to positive opening
The SGX Nifty, which is currently trading almost 38 points higher, is reflecting that Nifty may open at around the 11,135 levels.
Glenmark Pharmaceuticals plummets on US FDA warning letter
Glenmark Pharmaceuticals has informed the bourses that US FDA has issued a warning letter for its Baddi facility at Himachal Pradesh. The said facility was inspected by US FDA during 15th to 20th April of 2019.
Indoco Remedies gets USFDA approval for its Rasagiline ANDA
Indoco Remedies Limited has received the final approval for its Abbreviated New Drug Application (ANDA) for Rasagiline 0.5 mg and 1 mg tablets from the United States Food & Drug Administration (USFDA).
P2P Lending as an asset class: Should you cherish it?
There are various asset classes available in the market today. Now P2P lending has made its way to become one of them. So, should you consider investing via P2P lending? Let’s find out.
Index trend and stocks in action October 07, 2019
Now going ahead, bulls will set sight on the next crucial support level of 11,074 as it is a 61.8 per cent retracement of the recent upsurge and also the 50-DMA is placed near this level. On the upside, the 200-DMA, which is placed at 11,262, would now act as a stiff resistance for the bulls. The daily relative strength index is in falling trajectory and features in the neutral zone, the next crucial level to watch out is around 38-40 mark.
Flat start likely for the markets
Flat start likely for the markets
After days of relentless correction, bulls can finally heave a sigh of relief on Monday at least at the opening bell as early cues from SGX Nifty is indicating markets may began the session in the green, however, the gains are miniscule as SGX is trading with an uptick of 8 points at 11,214 levels. The week gone by was the worst week for the markets since May.
Mutual Fund Update: New Fund Offer (NFO)
Mutual Fund Update: New Fund Offer (NFO)
New Fund Offers (NFOs) that are open for subscription.
Lupin launches Mycophenolate Mofetil Capsules
Lupin has launched Mycophenolate Mofetil Capsules USP, 250 mg. The shares could be in focus on the following trading day as a reaction to the launch.
Expenses that can sabotage your retirement corpus
Everyone have a wish to retire peacefully specifically in a peaceful environment and enjoy their time with their loved ones. However, there are certain expenses that may burn your retirement corpus. Let’s find out what are they.